Atsushi Noda

发表

Discovery of ASP5878: Synthesis and structure-activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activity.

Ikumi Kuriwaki, M. Kameda, Kazuhiko Iikubo, 2022, Bioorganic & medicinal chemistry.

Reproductive and developmental toxicity screening test of tetrahydrofurfuryl alcohol in rats.

Atsushi Noda, M. Ema, M. Hirata-Koizumi, 2008, Reproductive toxicology.

Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus.

Atsushi Noda, Hiroshi Tomiyama, M. Takeuchi, 2012, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of C-glucosides with azulene rings as selective SGLT2 inhibitors for the treatment of type 2 diabetes mellitus: discovery of YM543.

Atsushi Noda, M. Takeuchi, Takayuki Suzuki, 2013, Bioorganic & medicinal chemistry.

Effects of sodium‐glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin‐induced type 1 diabetic rats

M. Sasamata, Atsushi Noda, Rumi Kihara, 2014, The Journal of pharmacy and pharmacology.

Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor

Atsushi Noda, Rumi Kihara, M. Shibasaki, 2013, Endocrine research.

Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo

M. Sasamata, Atsushi Noda, Rumi Kihara, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Higher susceptibility of newborn than young rats to 3-methylphenol.

Atsushi Noda, M. Ema, S. Fujii, 2003, The Journal of toxicological sciences.

Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.

M. Sasamata, Atsushi Noda, Rumi Kihara, 2013, European journal of pharmacology.

Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency.

Ikumi Kuriwaki, M. Kameda, Kazuhiko Iikubo, 2021, Bioorganic & medicinal chemistry.

Assessment of the acute toxicity of 16 veterinary drugs and a disinfectant to aquatic and soil organisms

Atsushi Noda, Yoshihiko Ito, N. Hirayama, 2019, Fundamental Toxicological Sciences.

Antidiabetic effects of SGLT2-selective inhibitor ipragliflozin in streptozotocin-nicotinamide-induced mildly diabetic mice.

Hiroshi Tomiyama, Atsushi Noda, M. Sasamata, 2012, Journal of pharmacological sciences.

Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo

M. Sasamata, Atsushi Noda, Rumi Kihara, 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.